Life Science Lending
The MidCap Financial Life Science Lending team has extensive experience financing venture backed and micro/small cap life science companies. We provide capital to development stage and early commercial stage biotech, specialty pharmaceutical, medical device, and diagnostics companies. Our capital serves as an attractive, minimally dilutive alternative to equity for financing product acquisitions, enhancing a product launch, or advancing development stage programs. We specialize in senior-secured term loans, but can also provide borrowing base-driven lines of credit for commercial stage companies.
The MidCap Financial Technology Lending team is focused on providing capital to private and public, commercial stage companies in the enterprise software, networking, internet and hardware industries. Our capital, structured as term loans and/or borrowing base-driven working capital lines of credit, supports sales & marketing growth, product expansion, financing working capital, acquisition financing and liquidity ahead of an IPO.
MidCap Financial Services, LLC*
President of Specialty Lending
email@example.com • 301-841-6437
William Gould is a co-founder of MidCap Financial and President of Asset Based and Life Sciences Lending. Prior to joining MidCap, Mr. Gould created and ran the life sciences venture finance practice for Merrill Lynch Capital Healthcare Finance. Mr. Gould also served as a Team Leader responsible for underwriting asset based and specialty real estate loans at Merrill Lynch Capital. From 2001 to 2003, Mr. Gould was a Vice President at GE Capital’s Healthcare Commercial Finance business unit where he led the asset based underwriting group. Mr. Gould also spent four years in the corporate and securities group of the law firm of Hogan and Hartson. Mr. Gould holds a B.A. in Philosophy from Haverford College and a J.D. from the University of Virginia School of Law.
Josh Groman, Ph.D.
Managing Director & Co-Head Life Sciences & Technology Finance
firstname.lastname@example.org • 301-841-6438
Josh Groman is currently head of underwriting for MidCap’s Life Science Lending group. Prior to joining MidCap, Dr. Groman was head of underwriting for life science transactions at Merrill Lynch Capital Healthcare Finance. From 2004 to 2007, he served as an Engagement Manager in the life sciences consulting practice at Leerink Swann & Company where he advised biotech, pharmaceutical and device manufacturers on product strategy, business development and M&A due diligence. Dr. Groman holds a Ph.D. in Human Genetics and Molecular Biology from the Johns Hopkins School of Medicine and has published 11 research articles in leading scientific and medical journals. He also holds a B.S. from the State University of New York/Syracuse University and an M.S. in Biology from Vanderbilt University.
Managing Director & Co-Head Life Sciences & Technology Finance
email@example.com • 404-994-7025
Chris York is currently head of originations for MidCap’s Life Sciences & Technology Finance Group. Mr. York brings more than 17 years of experience providing venture debt financing to private and public technology and life science companies. Mr. York was one of the founding members of the Merrill Lynch Capital Life Sciences Venture Debt team. Prior to Merrill Lynch Capital, Mr. York spent 6 years at Silicon Valley Bank where he was responsible for developing and maintaining relationships with venture capital and private equity firms throughout the East Coast. Prior to joining Silicon Valley Bank, Mr. York was a professional golfer for 2 years, playing on various professional tours throughout the world. Mr. York graduated from Georgetown University in Washington, D.C. with a B.S. in Finance.
Managing Director & Team Leader – Technology Finance
MMarziani@midcapfinancial.com • 312-488-4537
Michael Marziani was most recently a Managing Director at Ares Management, and Co-Head of Ares Venture Finance. Prior to joining Ares in 2012, Mr. Marziani was a Managing Director at BlueCrest Capital, where he focused on originating, structuring and negotiating investment opportunities. Mr. Marziani holds a B.S. from Fairfield University in Finance and an M.B.A. from the Northwestern University Kellogg School.
firstname.lastname@example.org • 415-992-2564
James Taylor is the director of MidCap’s Life Sciences Lending Group in San Francisco. Prior to joining MidCap, Mr. Taylor was the head of Silicon Valley Bank’s San Francisco lending team specializing in loans to biotech, medical devices and diagnostics companies. In this capacity, Mr. Taylor was responsible for expanding the Bank’s venture debt portfolio and servicing over 150 client relationships. Prior to joining Silicon Valley Bank, Mr. Taylor was a director of business development for the Export – Import Bank in Washington DC, responsible for business development in Virginia, Maryland, North Carolina and South Carolina. Mr. Taylor graduated from Hamilton College in Clinton, NY with a double major in history and French. In his spare time, James is an avid backcountry fly-fisherman and skier.
email@example.com • 312-234-0297
Colleen Kovas is an underwriter in MidCap’s Life Sciences Lending group. Prior to joining MidCap, Ms. Kovas was the Director of Portfolio Management at BlueCrest Capital Finance. Prior to that, Ms. Kovas was a member of the life sciences venture finance practice at Merrill Lynch Capital. Ms. Kovas began her career in corporate and financial public relations. Ms. Kovas holds a B.A., magna cum laude, in Government & International Studies from the University of Notre Dame.
firstname.lastname@example.org • 240-383-3120
Ross Hartman is a Director in MidCap’s Life Science Lending group. Mr. Hartman has nearly a decade of experience providing debt financing to public and private companies. Prior to joining MidCap, Mr. Hartman was a Senior Director at Oxford Finance where he was responsible for underwriting and portfolio management of life science venture loans. Prior to Oxford, Mr. Hartman was an Associate at MCG Capital, a middle market lender. Mr. Hartman holds a B.S. in Finance, summa cum laude, from Virginia Tech.
email@example.com • 240-383-1606
Nathan Rothschild is an underwriter in MidCap’s Life Science and Asset Based Lending groups where he is responsible for structuring and executing senior financings. Mr. Rothschild has held various roles at MidCap since 2012. He earned his Masters in Finance from the Owen Graduate School of Management at Vanderbilt University and a B.A. in Economics and Political Science, summa cum laude, from Vanderbilt University. He is a CFA charterholder.
* See "Firm Overview" page for information on MidCap Financial's relationship with MidCap Financial Services, LLC and Apollo Capital Management, L.P.